ReviewCurrent drug targets2025
Two Decades Rituximab Therapy in Anti-Neutrophil Cytoplasmic Antibody Associated Vasculitis.
Mohammad Amin Habibi et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ReviewCurrent drug targets2025
Mohammad Amin Habibi et al.PubMed ↗Publisher ↗
No numbers read from the abstract.